nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—Tamsulosin—DRD3—attention deficit hyperactivity disorder	0.025	0.384	CrCbGaD
Silodosin—Tamsulosin—ADRA2A—attention deficit hyperactivity disorder	0.0228	0.35	CrCbGaD
Silodosin—Tamsulosin—DRD2—attention deficit hyperactivity disorder	0.0173	0.266	CrCbGaD
Silodosin—UGT2B7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0023	0.00246	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00229	0.00245	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00229	0.00245	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00228	0.00244	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00226	0.00242	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00221	0.00237	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00216	0.00231	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00207	0.00222	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00203	0.00217	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00201	0.00215	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00196	0.0021	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00191	0.00204	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00191	0.00204	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00188	0.00202	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00188	0.00201	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00185	0.00198	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00179	0.00191	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00175	0.00187	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00175	0.00187	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00175	0.00187	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00172	0.00184	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0017	0.00182	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00168	0.0018	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00167	0.00178	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00165	0.00176	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00161	0.00173	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00159	0.0017	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00159	0.0017	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00156	0.00167	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00153	0.00164	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00153	0.00164	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00153	0.00163	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00153	0.00163	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0015	0.00161	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0015	0.0016	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00145	0.00156	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00145	0.00156	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00145	0.00155	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00145	0.00155	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00153	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00141	0.00151	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00141	0.00151	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00141	0.0015	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00139	0.00149	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00139	0.00149	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00138	0.00148	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00137	0.00146	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00136	0.00146	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00134	0.00143	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00132	0.00141	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00131	0.00141	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00129	0.00138	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00129	0.00138	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00127	0.00136	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00125	0.00134	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00125	0.00133	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00124	0.00133	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00123	0.00132	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00132	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00121	0.0013	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00121	0.00129	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00119	0.00127	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00119	0.00127	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00117	0.00125	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.00125	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00117	0.00125	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00117	0.00125	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—COMT—attention deficit hyperactivity disorder	0.00116	0.00124	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00115	0.00123	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00115	0.00123	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00115	0.00123	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00114	0.00122	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00113	0.00121	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00111	0.00119	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00111	0.00118	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00111	0.00118	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00109	0.00117	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00116	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00107	0.00115	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00107	0.00115	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00107	0.00115	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00107	0.00115	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00106	0.00114	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00113	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00103	0.0011	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00103	0.0011	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00102	0.0011	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00102	0.00109	CbGpPWpGaD
Silodosin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.001	0.00107	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.001	0.00107	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000972	0.00104	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000969	0.00104	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000954	0.00102	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000952	0.00102	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000949	0.00101	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000936	0.001	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000921	0.000985	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000919	0.000983	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000917	0.000981	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000907	0.00097	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000903	0.000966	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000892	0.000954	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000892	0.000954	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000882	0.000944	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000865	0.000925	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000863	0.000923	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000846	0.000905	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000843	0.000902	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000831	0.000889	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000816	0.000873	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000803	0.000859	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000802	0.000858	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000795	0.00085	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000792	0.000848	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000792	0.000848	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000784	0.000838	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000777	0.000831	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000768	0.000821	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000766	0.00082	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000764	0.000818	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000738	0.00079	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000731	0.000782	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000722	0.000772	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000701	0.00075	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000695	0.000743	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00069	0.000738	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000679	0.000726	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00066	0.000706	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000659	0.000705	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000659	0.000705	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000648	0.000693	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000646	0.000691	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000631	0.000675	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000628	0.000672	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000626	0.000669	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000615	0.000658	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000615	0.000658	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000607	0.00065	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000607	0.000649	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000603	0.000645	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000603	0.000645	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000599	0.000641	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000587	0.000628	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000586	0.000627	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000582	0.000623	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000577	0.000617	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000568	0.000608	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000566	0.000605	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000559	0.000597	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000552	0.00059	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000539	0.000576	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000536	0.000574	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000536	0.000573	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000532	0.000569	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000532	0.000569	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000529	0.000565	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000527	0.000563	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000524	0.00056	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000521	0.000558	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000519	0.000555	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000517	0.000553	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000514	0.00055	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000512	0.000548	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000511	0.000546	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00051	0.000546	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000504	0.000539	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000501	0.000536	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000501	0.000536	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000496	0.00053	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000487	0.000521	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000476	0.000509	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000472	0.000504	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00047	0.000502	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000465	0.000498	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000464	0.000496	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000463	0.000495	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000461	0.000493	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000458	0.00049	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000454	0.000485	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000453	0.000485	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000448	0.000479	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000445	0.000476	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000433	0.000463	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000426	0.000456	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000426	0.000456	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000419	0.000448	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000417	0.000446	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000412	0.00044	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000407	0.000435	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000399	0.000427	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000396	0.000424	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000396	0.000424	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000379	0.000405	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000374	0.0004	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000373	0.000399	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00036	0.000385	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000356	0.000381	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000354	0.000379	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000347	0.000371	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000343	0.000367	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000336	0.000359	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00033	0.000353	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000329	0.000352	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000326	0.000349	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000314	0.000336	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000309	0.000331	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000304	0.000325	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000299	0.00032	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000292	0.000313	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000288	0.000308	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000279	0.000298	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000275	0.000294	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000274	0.000293	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00027	0.000289	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000265	0.000284	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000256	0.000273	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000252	0.000269	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000247	0.000265	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000246	0.000263	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000246	0.000263	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000243	0.00026	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000242	0.000258	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00024	0.000257	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000225	0.00024	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000224	0.000239	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000219	0.000234	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000213	0.000227	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000196	0.00021	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000187	0.0002	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000176	0.000189	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000171	0.000183	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000157	0.000168	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000151	0.000162	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000151	0.000162	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000149	0.000159	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000149	0.000159	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000148	0.000158	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000138	0.000148	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000121	0.000129	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000115	0.000123	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000113	0.00012	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.35e-05	0.0001	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	9.17e-05	9.81e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	9.1e-05	9.74e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.3e-05	8.88e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	6.38e-05	6.82e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.93e-05	4.2e-05	CbGpPWpGaD
